Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Trial Profile

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Apr 2013

At a glance

  • Drugs Bromfenac (Primary)
  • Indications Ocular inflammation; Ocular pain; Postoperative pain
  • Focus Therapeutic Use
  • Sponsors ISTA Pharmaceuticals
  • Most Recent Events

    • 09 Apr 2013 US FDA has approved bromfenac according to a Bausch and Lomb media release.
    • 17 Aug 2011 New trial record
    • 14 Jul 2011 Results of a pooled analysis of two identically-designed studies (204785 and 204793) published in the Current Medical Research and Opinion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top